Series
Gastrointestinal
Status
Published
Date
Number of report
055
Diagnostic endoscopic procedures on the upper gastrointestinal tract
Ask the expert
The report presents a summary of reimbursement situation for diagnostic endoscopic procedures on the upper gastrointestinal tract for benign and malignant diseases in outpatient settings.
The following procedures will be considered:
- Esophagoscopy
- Gastroscopy
- Duodenoscopy
The report will consider both stand-alone diagnostic procedures and in combination with biopsy of lesions.
The only reimbursement within public / statutory health insurance systems is considered.
Report includes essential information about reimbursement and national funding, including:
- Brief overview of reimbursement system for medical devices
- Procedure coding for technology
- Diagnosis coding
- Payment mechanism for technology
- Reimbursement tariffs for technology
- Restrictions in indications or scenarios for use of technology
- Policy considerations by payers and policy-makers about technology
Reimbursement information is provided for the following geographies:
- Austria
- Belgium
- Denmark
- England (UK)
- France
- Germany
- Italy
- Netherlands
- Norway
- Sweden
- Switzerland
It is also possible to add analysis in Czech Republic, Finland, Hungary, Romania, Russia and Turkey.
Manufacturers of endoscope equipment for the upper gastrointestinal tract include:
- Alltion (Fiber-GIS)
- Aohua Ednoscopy (FHD-GT, VGT, VME)
- Cogentix Medical (PrimeSight)
- Cook Medical (Shooter Saeed, Shooter Universal Saeed)
- Endomed Systems (Duo, Combo-2)
- Fujifilm Holdings Corporation (Eluxeo EG, ED)
- Huger Endoscopy System (GVE)
- Interscope (EndoRotor)
- IntroMedic (E.G. Scan)
- KARL STORZ GmbH & Co. KG (Silver Scope, Tele Pack X)
- Olympus (EVIS EXERA-Gif)
- Pentax medical (MagniView EG, Transnasal EG, G-EYE)
- SonoScape (EG-330 series)
- Stryker Corporation (1588 AIM)
Table of content is not available at the moment. Report is still ongoing.
18
Feb 2022
Dutch Organization for Health Research and Development, ZonMw awarded eight projects under the "Healthcare Evaluation and Appropriate Use" program, including two projects for geriatric care, two projects for cancer, per one project for cardiovascular, neurovascular, and dermatology care.
Read more16
Nov 2021
In late October 2021, the BfArM (Federal Institute for Drugs and Medical Devices) has published the final version of the 2022 OPS procedure coding classification. The OPS, together with the ICD-10-GM (International Statistical Classification of Diseases and Related Health Problems, 10th revision, German Modification), forms the basis for the reimbursement systems in outpatient and inpatient care.
Read more04
Nov 2021
On September 16, 2021, the Federal Joint Committee (G-BA) has decided that it would not evaluate the proton therapy in a number of indications, including esophageal cancer and inoperable hepatocellular carcinoma (HCC).
Read more19
Oct 2021
In late September 2021, the Austrian version of the DRG system (LKF) 2022 model with the relevant supplementary documents was published in Austria. The document "Changes and innovations in the 2022 LKF model" (Änderungen und Neuerungen in den LKF-Modellen 2022) summarizes the most significant changes and innovations in the LKF model for inpatient and outpatient care. The newly added procedure codes concern mainly the cardiovascular, E-Health, and gastrointestinal area.
Read more28
Jun 2021
In mid-June 2021, the document "Changes and innovations in the 2022 LKF model" (Änderungen und Neuerungen in den LKF-Modellen 2022) was published. The document summarizes the most significant changes and innovations in the LKF model for inpatient and outpatient care. The newly added procedure codes concern mainly the cardiovascular, e-Health, and gastrointestinal area.
Read more